Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer-Reference-Cited by-同舟云学术

Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer

Published:2020-01-07 Issue:11 Volume:26 Page:2654-2663
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Schoenfeld Adam J.^ORCID,Chan Joseph M.,Kubota Daisuke,Sato Hiroki,Rizvi Hira,Daneshbod Yahya,Chang Jason C.,Paik Paul K.,Offin Michael^ORCID,Arcila Maria E.,Davare Monika A.,Shinde Ujwal,Pe'er Dana,Rekhtman Natasha^ORCID,Kris Mark G.,Somwar Romel,Riely Gregory J.,Ladanyi Marc,Yu Helena A.

Funder

HHS | NIH | National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer;Cell Death & Disease;2024-09-03

2. Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification;JCO Precision Oncology;2024-09

3. Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC;ESMO Real World Data and Digital Oncology;2024-09

4. An identity crisis for lung cancer cells;Science Translational Medicine;2024-08-14

5. Neutrophils Recruited by NKX2‐1 Suppression via Activation of CXCLs/CXCR2 Axis Promote Lung Adenocarcinoma Progression;Advanced Science;2024-08-07